On Friday a High Court judge threw out a legal challenge to the Pathways trial — a King's College London study that will give puberty blockers to more than 220 children aged 11 to 16, the first new prescriptions since the UK banned them outside research in 2024. That's the event. Now here are the two headlines Britain actually saw. * The Guardian: "High court clears way for clinical trial giving puberty blockers to children." The subject of that sentence is the court. The verb is "clears way" — the language of green lights, lifted barriers, roads opening. The trial is just the vehicle that's been waiting patiently at the gate. * The BBC: "Puberty blockers trial can start recruiting children after judge rejects legal challenge." Now the subject is the trial itself, and what the trial does is "start recruiting children." The actual news — a judge issued a ruling — got demoted to the subordinate clause, trailing at the end like a footnote. * To be precise, because this topic deserves precision: "recruiting" is completely standard clinical-trial vocabulary. Researchers recruit participants; that's just the word. But a headline travels without its methods section. In a push notification, "recruiting children" doesn't read like paperwork — it reads like the thing a warning poster tells you to watch out for. Of all the technically correct phrasings available, the BBC picked the one that could double as the legal challengers' campaign slogan. * Here's the part that makes it interesting rather than just annoying: underneath those two headlines, the articles are nearly the same. Both quote Mr Justice Chamberlain saying no claim had "a realistic chance of success." Both note each child will have been assessed over "many months" by specialists. Both give the challengers room to respond — Keira Bell called the ruling "a tragedy" in a quote she gave, of all places, to the BBC. The reporting converges. The packaging diverges. * And packaging is most of the product. This is probably the most fought-over health story in Britain — the trial only exists because the Cass review found the existing evidence "remarkably weak" and asked for real data instead of louder opinions. Most people will never read past the headline. One set of readers saw a road open on Friday. Another set heard an alarm go off. It was the same ruling.